glp 1 effects on brain GLP-1 and Anesthesia: Considerations and Cautions for CRNAs glp 1 gi side effects

It is not FDA-approved, and no medical or healthcare use is suggested

GLP-1 agonists are used to help manage type 2 diabetes and obesity as well as a few other conditions

Drugs with a longer half-life may take longer to start working, but their effects persist for longer, and they may only need to be dosed once a day, once a week, once a month, or even less frequently

Melanotan II (MT2) is a synthetic analogue of alpha-melanocyte-stimulating hormone (-MSH), a naturally occurring peptide hormone

This session is packed with insights from MMS experts on how to: Select the right regulatory path at the right time Align protocols and endpoints to meet expectations Use early signals to support stronger submissions Thank you to Sam Miller Ben Kaspar and Ben Dudley for lending their insights on how data, modeling, and regulatory strategy intersect to drive progress

[13] recently reported that GLP-1 RAs are not associated with an increased risk of intestinal obstruction in patients with inflammatory bowel disease using Danish health registries